twitter
en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2019
vol. 121
 
Share:
Share:
abstract:
Case report

Ophthalmological manifestations in antiphospholid syndrome – case series

Aleksandra Ostrowska-Spaleniak
1
,
Karolina Krix-Jachym
1
,
Marek Rękas
1

  1. Klinika Okulistyki Wojskowego Instytutu Medycznego w Warszawie Kierownik: prof. dr hab. n. med. Marek Rękas
Online publish date: 2019/06/05
View full text Get citation
 
PlumX metrics:
The antiphospholipid syndrome is a systemic autoimmune hypercoagulable state, with highly variable symptomatology such as venous and /or arterial thrombosis and obstetric morbidity. Its serological markers are antiphospholipid antibodies: lupus anticoagulant, anticardiolipin antibodies and anti-β2-glycoprotein I antibodies. Deep vein thrombosis is the most common complication of antiphospholipid syndrome occurring in about half of patients; thrombotic events may affect many important organs: lungs, skin, brain, liver, kidneys, adrenal glands, heart and eyes. Ocular involvement may occur in about 80% of patients with antiphospholipid syndrome and may be its first clinical manifestation. Retinal arterial and vein occlusion accompanied by various neurological symptoms, such as anterior ischemic optic neuropathy and amaurosis fugax, can be considered as typical of anti­phospholipid syndrome. The complications of antiphospholipid syndrome are treated with anticoagulants in order to prevent further thrombotic events.
keywords:

antiphospholipid syndrome, retinal vein occlusion, retinal artery occlusion, anterior ischemic optic neuropathy

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.